LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Albert Einstein College of Medicine
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Albert Einstein College of Medicine (4)
2024
-
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
Lung Cancer, Vol. 189
-
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up
Journal of Thoracic Oncology, Vol. 19, Núm. 8, pp. 1228-1241
2023
-
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC
JTO Clinical and Research Reports, Vol. 4, Núm. 1
-
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study
Journal of Clinical Oncology, Vol. 41, Núm. 11, pp. 1999-2006